Delivers personalized psychiatric and neurological treatment by matching drugs to patients using proprietary neuronal readout technology.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
NeuroKaire is developing personalized medicine solutions to optimize treatment for psychiatric and neurological diseases. The company’s proprietary and innovative technology helps physicians find the best treatment for their patients. NeuroKaire uses its unique neuronal readout technology to rapidly test approved antidepressants and drug combinations against an individual patient’s unique neurological biomarkers. Combined with patients’ genetic and medical history, NeuroKaire can improve selection of the optimal drug therapy for each patient. This opens the door to faster treatment, fewer side effects, and lower dosing, and the elimination of arduous trial-and-error treatment protocols and needless loss of life. NeuroKaire also enables pharmaceutical and biotechnology companies to bring precision medicine into drug development throughout the developmental pipeline across psychiatry and neurology.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Investors
GreyBird Ventures
Jumpspeed Ventures
Meron Capital
NeuroKaire Valuations & Financials
View real-time NPM data on NeuroKaire stock including daily NeuroKaire stock price estimates, valuation history, and historical share price information. Access NeuroKaire financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track NeuroKaire pricing across six independent market signals. Looking for private company due diligence data sources on NeuroKaire? Get in touch to learn more.
Similar Companies
like NeuroKaire
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Veris AI
AI & Machine Learning
AI training platform offering realistic simulated environments for enterprises to safely develop, test and improve AI agents before deployment.
Creatify
AI & Machine Learning
Enables users to rapidly generate high-quality video ads for products and services using advanced artificial intelligence.
Playcast
Media & Entertainment
Enables peer-to-peer game streaming that allows users to broadcast gameplay directly while viewers connect through web browsers.
Hypercraft
Mobility & Transportation
Designs and develops advanced electric and hybrid powertrains for OEMs, enabling efficient, high-performance, and sustainable vehicle solutions.
Connecteam
Enterprise Software
Streamlines scheduling, communication, and HR tasks for deskless teams through a unified app.
Human.org
AI & Machine Learning
Specializes in marketing, technology, and AI to empower individuals and organizations, while building and scaling impactful ventures.
The Demex Group
FinTech
Offers protection which addresses frequent weather-based losses by modeling risk and transferring financial exposure for weather perils.
MyWoundDoctor
Healthcare & Life Sciences
Facilitates remote monitoring and expert-guided treatment plans for improved healing outcomes.
FAQ
We have answers
NeuroKaire stock does not trade on public stock exchanges. NeuroKaire stock is considered a private security and you need to be an accredited investor to trade shares. To invest in NeuroKaire stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
NeuroKaire Stock does not trade on public stock exchanges. In order to sell NeuroKaire shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
NeuroKaire does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view NeuroKaire share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for NeuroKaire stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell NeuroKaire stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in NeuroKaire stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
NeuroKaire is a private company and has not had an IPO. There is currently no NeuroKaire IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to NeuroKaire IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
